These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3685720)

  • 1. A cost-function approach to the design of reliability studies.
    Eliasziw M; Donner A
    Stat Med; 1987 Sep; 6(6):647-55. PubMed ID: 3685720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Issues of cost and efficiency in the design of reliability studies.
    Shoukri MM; Asyali MH; Walter SD
    Biometrics; 2003 Dec; 59(4):1107-12. PubMed ID: 14969491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size requirements and the cost of a randomized clinical trial with repeated measurements.
    Bloch DA
    Stat Med; 1986; 5(6):663-7. PubMed ID: 3823673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simple, defensible sample sizes based on cost efficiency.
    Bacchetti P; McCulloch CE; Segal MR
    Biometrics; 2008 Jun; 64(2):577-85; discussion 586-94. PubMed ID: 18482055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variance estimation in clinical studies with interim sample size re-estimation.
    Miller F
    Biometrics; 2005 Jun; 61(2):355-61. PubMed ID: 16011681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response adaptive designs with a variance-penalized criterion.
    Yi Y; Wang X
    Biom J; 2009 Oct; 51(5):763-73. PubMed ID: 19757432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of multistage testing times and critical values in clinical trials.
    Brittain EH; Bailey KR
    Biometrics; 1993 Sep; 49(3):763-72. PubMed ID: 8241372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of measurement reliability in clinical trials.
    Lachin JM
    Clin Trials; 2004; 1(6):553-66. PubMed ID: 16279296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian hypothesis testing in two-arm trials with dichotomous outcomes.
    Zaslavsky BG
    Biometrics; 2013 Mar; 69(1):157-63. PubMed ID: 23002906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample size requirements for reliability studies.
    Donner A; Eliasziw M
    Stat Med; 1987 Jun; 6(4):441-8. PubMed ID: 3629046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel, AA/BB, AB/BA and Balaam's design: efficient and maximin choices when testing the treatment effect in a mixed effects linear regression.
    Candel MJ
    Pharm Stat; 2012; 11(2):97-106. PubMed ID: 22337606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods of estimation in log odds ratio regression models.
    Breslow NE; Cologne J
    Biometrics; 1986 Dec; 42(4):949-54. PubMed ID: 3814734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approximate case influence for the proportional hazards regression model with censored data.
    Cain KC; Lange NT
    Biometrics; 1984 Jun; 40(2):493-9. PubMed ID: 6386066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covariate analysis of competing-risks data with log-linear models.
    Larson MG
    Biometrics; 1984 Jun; 40(2):459-69. PubMed ID: 6487729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimators and tests in the analysis of multiple nonindependent 2 x 2 tables with partially missing observations.
    Lachin JM; Wei LJ
    Biometrics; 1988 Jun; 44(2):513-28. PubMed ID: 3291958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomization and efficiency in Zelen's single-consent design.
    Matts J; McHugh R
    Biometrics; 1987 Dec; 43(4):885-94. PubMed ID: 3427173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design by L. Frison and S.J. Pocock, Statistics in Medicine 1992; 12: 1685-1704.
    Julious SA
    Stat Med; 2000 Nov; 19(22):3133-5. PubMed ID: 11113948
    [No Abstract]   [Full Text] [Related]  

  • 18. Planning the duration of accrual and follow-up for clinical trials.
    Morgan TM
    J Chronic Dis; 1985; 38(12):1009-18. PubMed ID: 4066889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designed extension of studies based on conditional power.
    Proschan MA; Hunsberger SA
    Biometrics; 1995 Dec; 51(4):1315-24. PubMed ID: 8589224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated significance tests for clinical trials with a fixed number of patients and variable follow-up.
    Armitage P; Stratton IM; Worthington HV
    Biometrics; 1985 Jun; 41(2):353-9. PubMed ID: 4027318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.